2021-03-22 · Carl-Johan Wachtmeister, Kommunikationschef Enzymatica AB Tel: 0701-88 50 21 | E-post: Investor Relations: christian@borsveckan.se 070-571 65 88

Investor Relations. Our Investor Relations pages present published information about INVISIO, the share, ownership structure and data on future information and presentation events. This section aims to offer a broad selection of financial information to facilitate assessment of INVISIO.

Acconeer AB:s årsredovisning för 2020 finns från och med idag tillgänglig på bolagets hemsida, investor.acconeer.com. Investor relations. På Archelons hemsida publiceras: Periodisk ekonomisk information i form av kvartalsrapporter, bokslutskommunikéer, årsredovisningar samt pressmeddelanden i samband med händelser av betydelse. Archelon AB – Södra Allégatan 13 – 413 01 Göteborg. Investor Relations News More news from SEB. 30 Mar 2021 14:44 SEB’s Annual General Meeting 2021.

The market for over-the-counter cold products amounted to USD 21.5 billion in 2017. Other directorships: Board member of Aspekta AB, the Swedish Investor Relations Association (SIRA), Wacht & Troy AB and Trolle-Wachtmeisters Medicinska Forskningsstiftelse. Education: BA in business administration and political science. Holdings in Enzymatica: 250 000 shares 100 000 warrants 2021-03-29 2021-03-29 STOCKHOLM, March 29, 2021 /PRNewswire/ -- The Board of Directors of Enzymatica AB (publ) ("Enzymatica" or the "Company") has decided to carry out a rights issue amounting to SEK 59.1 million, with preferential rights for existing shareholders, by exercising the authorization of a new rights issue from the Annaul General Meeting 2020 (the "Rights issue"). 2021-03-22 Enzymatica AB. BioStock: Enzymatica har bäddat för fortsatt tillväxt (Cision) Sammantaget var 2020 ett aktivt år för Enzymatica vilket ledde det till en omsättning om 111,2 Mkr, Investor Relations: christian@borsveckan.se 070-571 65 88 Enzymatica AB / Ännu lite till om hudsalvan.

Ronni Funch Olsen rofo@boozt.com. Press releases. Read more.

Investor Relations Ambea is to provide the capital market with reliable, fair, updated and correct information about the company’s business, strategy and financial position. Our ambition is to be a professional, transparent and a trustworthy company.

17 March. News.

04/08/2017, Enzymatica AB, ASGEIR ASGEIRSSON, Styrelseledamot/ 03/08/2017, Nordea Bank AB (publ), Rodney Alfvén, Head of Investor Relations

5 April, 2019. Notice of annual general meeting 2019 in Enzymatica AB (publ) The shareholders in Enzymatica AB (publ), reg. no 556719-9244 (the “Company”) are hereby invited to attend the annual general meeting (“AGM”) to be held on Tuesday 7 May 2019 at 14.30 CEST at Elite Hotel Ideon, Scheelevägen 27, 223 63 Lund. Investor Relations Ambea is to provide the capital market with reliable, fair, updated and correct information about the company’s business, strategy and financial position. Our ambition is to be a professional, transparent and a trustworthy company. Dec 23, 2020 OFFHUS, Offentliga Hus i Norden AB ENZY, Enzymatica AB but are not limited to factors detailed in Nasdaq's annual report on Form 10-K, Dec 14, 2015 relations. We could predict a seasonality of revenues for at least a coming year, Enzymatica AB is the best seller of common cold products in 2014 in Sweden.

Investor Relations.
Hattpartiet

Ideon Science Park SE-223 70 Lund, Sweden Tel: +46 (0)46-286 31 00 E-mail: info@enzymatica.se Enzymatica operates on a large market, colds, with strong underlying growth.

Mar 7, 2021 The kr1.9b market-cap company announced a latest loss of kr13m on 31 December 2020 for its most recent financial year result.
Versal efter kolon

styrelsen bar och bistro
fa tillbaka korkortet efter rattfylla
fördelar med gemensam valuta
få underhåll retroaktivt
snabbt fikabröd

Reports & Sec Filings AB News Center About AB Upcoming Events Corporate Responsibility Context: The AB Blog on Investing AB is committed to expand our global leadership in active management, lead in private and public alternatives, and continue to improve our efficiency—all while acting responsibly—for the benefit of our clients

Awards · Careers · Information and History · Investor Relations · News @ IBKR · Press and Media · Regulatory Reports. Kursrörelser i Enzymatica, Moberg Pharma och Pledpharma · The 'Severest Form of PMS' Swedish investor site on increased valuation of Asarina Pharma. Got tips on another noted company with a seat in Lund Bioextrax Website https://bioextrax.com/investor-relations/ Noting date 2020-04-28 Now have 63 noted Company profile for Thule Group AB ADR including key executives, insider trading, Thule Group AB, 5653 Sweden AB, Enzymatica AB, Aligro Management AB, AAK AB Fredrik Erlandsson SVP-Communications & Investor Relations.

Gratis cv mall ladda ner
personbevis resa norge

Anmälan senast den 5 mars till ir@enzymatica.se. Stockholm Tina Dackemark Lawesson, Senior Communications Officer Enzymatica AB

Senaste nyheter om - Enzymatica, aktieanalys, kursutveckling och rapporter. Enzymatica komplett bolagsfakta & börsnyheter från Analysguiden. Prenumerera här. 2021-03-22 · Carl-Johan Wachtmeister, Kommunikationschef Enzymatica AB Tel: 0701-88 50 21 | E-post: Investor Relations: christian@borsveckan.se 070-571 65 88 2021-03-22 · Carl-Johan Wachtmeister, Communication manager Enzymatica AB Phone: +46 (0)701-88 50 21 Investor Relations: christian@borsveckan.se 070-571 65 88 Enzymatica AB is a Swedish life science company that develops and sells medical devices for infection-related diseases.

Enzymatica är ett life science-bolag som utvecklar och säljer medicintekniska produkter mot infektionsrelaterade sjukdomar. Produkterna baseras på barriärteknologi, som inkluderar marina enzymer. Bolagets första produkt är ColdZyme® Munspray som kan förhindra förkylning, och kan förkorta sjukdomsperioden.

Investor Relations. IR News / IR Nyheter LIFEASSAYS AB Sölvegatan 43 A SE-223 70 Lund, Sweden Phone +46 46 286 5400. US ABREOS BIOSCIENCES 2223 Avenida de la Playa About Enzymatica AB Enzymatica is a life science company who develops and sells medical device products against infectious-related diseases. Over a short period the company has developed a unique oral spray for colds, ColdZyme®, and launched it on six markets. The product has become one of the leading articles for colds in Swedish pharmacies.

Bevaka ämnet för att hålla dig uppdaterad om Enzymatica. Enzymatica AB: Kortare förkylningar för elitidrottare med ColdZyme. I denna prospektiva observationsstudie, som är den första randomiserade och kontrollerade studien som undersöker effekten av ColdZyme hos elitidrottare, randomiserades 123 elitidrottare inom uth Press release.